Peptides DB
Research-centric peptide and protocol reference hub
Study 10 of 15Lanreotide literatureAsia-Pacific journal of oncology nursing · Observational2026

Comparative predictive performance of three machine learning algorithms for acute radiation enteritis risk among patients with cervical cancer undergoing radiotherapy: A prospective cohort study.

The Random Forest model showed excellent predictive performance for acute radiation enteritis in cervical cancer patients, but further validation is needed before clinical implementation.

Read at Asia-Pacific journal of oncology nursingAdd to compare

Where it sits

this study against the rest of the lanreotide corpus
0
Preclinical
12
Observational · this one
0
Open-label
2
Randomised
1
Reviews

Summary and findings

This study aimed to develop a machine learning-based risk prediction model for acute radiation enteritis (ARE) in patients with cervical cancer undergoing radiotherapy. The study included 386 patients and evaluated three models: Logistic Regression, Decision Tree, and Random Forest. The Random Forest model showed the highest predictive performance.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Random Forest model AUC was 0.961.n=3862026

Abstract

The authors’ words, as Asia-Pacific journal of oncology nursing supplied them

<h4>Objective</h4>To develop a machine learning-based risk prediction model for acute radiation enteritis (ARE) in patients with cervical cancer, providing a new method for early and accurate prediction of ARE during radiotherapy.<h4>Methods</h4>This prospective study enrolled patients with cervical cancer undergoing radiotherapy from March 2024 to March 2025. The patients were randomly divided into training and test sets at a 7:3 ratio. Prediction models were constructed using Logistic Regression (LR), Decision Tree (DT), and Random Forest (RF) algorithms. Model performance was evaluated based on the area under the receiver operating characteristic curve (AUC), accuracy, precision, sensitivity, specificity, and F1-score.<h4>Results</h4>The incidence of ARE was 52.85% (204/386). Among the three models, the Random Forest model demonstrated the best performance, with an AUC of 0.961, sensitivity of 0.934, and F1-score of 0.905. These performance metrics were consistently higher than those of the LR (AUC, 0.860; sensitivity, 0.739; F1-score, 0.736) and DT (AUC, 0.910; sensitivity, 0.887; F1-score, 0.873) models. The RF model showed good clinical utility in effectively identifying high-risk patients for early intervention. Feature importance ranking derived from the RF model identified the parametrial dose, radiotherapy time, clinical stage, rectal V40, age, Platelet-to-Lymphocyte Ratio (PLR), concurrent chemotherapy, and hypertension as the most influential predictors, in descending order of importance.<h4>Conclusions</h4>The RF-based risk prediction model exhibited excellent performance in assessing the risk of ARE among patients with cervical cancer undergoing radiotherapy, thereby enabling individualized risk assessment and facilitating early preventive strategies.

Background

This paper addresses the need for accurate prediction of acute radiation enteritis (ARE) in cervical cancer patients undergoing radiotherapy. Prior studies have indicated that ARE can significantly impact treatment outcomes, but predictive models have been limited. This study is important as it explores machine learning algorithms to enhance risk prediction and potentially improve patient management.

Methods

This prospective cohort study enrolled patients with cervical cancer undergoing radiotherapy from March 2024 to March 2025. Patients were randomly divided into training and test sets at a 7:3 ratio. Three machine learning models were constructed: Logistic Regression, Decision Tree, and Random Forest. Model performance was evaluated using metrics such as AUC, accuracy, sensitivity, specificity, and F1-score.

Results

The incidence of acute radiation enteritis (ARE) was 52.85% (204/386). The Random Forest model demonstrated the best performance with an AUC of 0.961, sensitivity of 0.934, and F1-score of 0.905. In comparison, the Logistic Regression model had an AUC of 0.860, sensitivity of 0.739, and F1-score of 0.736, while the Decision Tree model had an AUC of 0.910, sensitivity of 0.887, and F1-score of 0.873.

Interpretation

The findings suggest that the Random Forest model outperforms traditional methods in predicting ARE risk, which aligns with previous literature highlighting the utility of machine learning in clinical predictions. However, while the AUC of 0.961 indicates strong statistical performance, the clinical significance of these findings remains to be fully validated in diverse populations. Limitations such as single-site data and potential overfitting must be considered when interpreting the results.

Key findings

  • Incidence of ARE was 52.85% (204/386).
  • Random Forest model AUC was 0.961, sensitivity was 0.934, F1-score was 0.905.
  • Logistic Regression model AUC was 0.860, sensitivity was 0.739, F1-score was 0.736.
  • Decision Tree model AUC was 0.910, sensitivity was 0.887, F1-score was 0.873.

Limitations

  • Single-site study limits generalizability.
  • Potential for overfitting in machine learning models.
  • Short follow-up duration may not capture long-term outcomes.
  • Not reported in abstract.

Elsewhere in the Lanreotide corpus

AOrforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial.Nature medicine · 2026 · Cohort 1 maintained an MBE of 74.7% body weight reduction with orforglipron vs 49.2% with placebo at week 52, P<0.001.HumanBNeuroendocrine Tumor Chromogranin A Response following Synthetic Somatostatin analog (Lanreotide): First Observations from an Isolated Duodenal Neoplasmbiorxiv-preprint · 2023 · Serum CgA reduced from 3636 to <100 ng/mL after five months.HumanBPatient Point of View of the diagnosis, treatment and follow up in acromegaly: Single center study from a tertiary centerbiorxiv-preprint · 2024 · Overall disease control achieved in 38 patients (65.5%).HumanCHeterozygous Men1+/T knockout mice do not develop bronchopulmonary neuroendocrine hyperplasia or neoplasia but bronchial adenocarcinomabiorxiv-preprint · 2024 · No bronchopulmonary neuroendocrine cell hyperplasia or neoplasia detected in 30 mice evaluated.AnimalB<p class="MDPI12title"><span lang="EN-US" style="mso-bidi-font-size: 18.0pt;">In vivo and In Vitro Efficacy of Statin Therapy in Combination with Somatostatin Analogues in Advanced Bronchopulmonary Neuroendocrine Tumorsbiorxiv-preprint · 2026 · Not reported in abstract.HumanARandomized, placebo-controlled phase 3 trial evaluating safety, immunogenicity, and reactogenicity of RSVPreF3-Mat in high-risk pregnant women and their infants.Human vaccines & immunotherapeutics · 2026 · n=169 · Preterm birth occurred in 18.2% and 19.7% of participants in the vaccine and placebo groups, respectively.Human